Who invested in Groove Biopharma?
Groove Biopharma's investors include ARCH Venture Partners, Versant Ventures, OVP Venture Partners, Washington Research Foundation and Alexandria Real Estate Equities.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$9.9Mraised across 2 rounds since 2010, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by finsmes.comSEC filing: $4.5M sold, first sale Dec 2011
From the SEC filings it signed: 3 on the team.
On the board, as filediBrian AtwoodChad WaiteMerl F. HoekstraSteven GillisThong Le
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Groove Biopharma's investors include ARCH Venture Partners, Versant Ventures, OVP Venture Partners, Washington Research Foundation and Alexandria Real Estate Equities.
Groove Biopharma has raised $9.9M across 2 rounds since 2010.
Groove Biopharma's most recent round was a Series B of $6.0M in Dec 2011.
Its most recent round, $6.0M in Dec 2011, is also its largest on record.
Groove Biopharma's first round on record, in Apr 2010, was backed by ARCH Venture Partners, Versant Ventures and Alexandria Real Estate Equities and 2 others.
Groove Biopharma's latest named round is a Series B, in Dec 2011.
Groove Biopharma is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.